Ninepoint Partners’s Zoetis ZTS Stock Holding History

Ninepoint Partners’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,650	Closed	-$720K	–	106
2023 Q4	$720K	Buy	+3,650	New	+$646K	0.08%	52

Other funds holding ZTS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ninepoint Partners's ZTS Position: Q1 2024 in Review

Ninepoint Partners sold out of Zoetis (ZTS) in Q1 2024, closing a stake of 3,650 shares — an estimated $720K sold.

Ninepoint Partners first reported a position in ZTS in Q4 2023 and held it in 1 quarter. The position peaked at $720K in Q4 2023. 1,736 funds tracked by Wall St. Rank hold ZTS as of Q1 2024.

Ninepoint Partners reported no remaining Zoetis position as of Q1 2024 after selling out during the quarter.
Ninepoint Partners sold 3,650 Zoetis shares in Q1 2024, an estimated $720K.
Ninepoint Partners first reported a position in Zoetis in Q4 2023 and held it in 1 quarter.
Ninepoint Partners's Zoetis position peaked at $720K in Q4 2023.
1,736 funds tracked by Wall St. Rank held Zoetis as of Q1 2024.

Based on Ninepoint Partners's 13F filing for Q1 2024, filed 13 May 2024.